我要投票 龙牡在钙片行业中的票数:262
· 外 推 电 报 ·
2025-06-01 08:15:05 星期日

【龙牡是哪个国家的品牌?】

龙牡是什么牌子?「龙牡」是武汉健民药业集团股份有限公司旗下著名品牌。该品牌发源于湖北,由创始人刘勤强在2002期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力龙牡品牌出海!将品牌入驻外推网,定制龙牡品牌推广信息,可以显著提高龙牡产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

龙牡壮骨颗粒是武汉健民集团旗下一个有着近20年辉煌历史、创造了中国医药界长盛不衰奇迹的知名品牌,整整抚育了中国两代儿童的健康成长。

龙牡壮骨颗粒的的主要药材(如茯苓、麦冬等)都直接选用武汉健民集团专门建设的GAP药材种植基地的原料,药材天然地道。生产过程中的每个环节、每道工序都有严格的质控标准,做到了“不合格的原料不进厂,不合格的半成品不转到下道工序,不合格的产品不出厂”。

“龙牡”的面世和畅销,创造了令人惊叹的市场业绩和品牌价值,也使得武汉健民——一个有着悠久历史、而却依然年轻的企业焕发出勃勃的生机,从此享誉长城内外,大江南北。

“龙牡”,曾经独领儿童补钙产品市场的风骚。而如今,它却受到了来自其它同类竞品的强力竞争和挑战,面临着市场份额被不断蚕食和瓜分的严峻局面。抚育了中国整整二代人的茁壮成长。

1985年在武汉市儿童医院出生,填补了我国以中药为主体,防治小儿佝偻病的空白;

1990年被收载入湖北省药品标准;

1992年被列为国家唯一的补钙一级中药保护品种;

1993年被中国儿童保护中心推荐为最佳小儿补钙、促进钙质吸收药品;

1994年被全国佝偻病防治协作组列为首推中成药;

1995年被收载入卫生部药品标准;

1999年被列为国家基本药物;

2000年被中国药典2000版收载;

2002年被列为国家处方药与非处方药(OTC)双跨品种;

同年,被《中医儿科学》(新世纪全国高等中医院校规划教材)收载。

武汉健民为中国医药工业50强企业,集团股份有限公司是国家重点高新技术企业、全国中成药小儿用药生产基地、全国重点中药企业。集团的前身是中国最古老的四大中药名店之一的叶开泰药店,距今已有近四个世纪的历史,现拥有十余个子公司,集生产、科研、经贸于一体,年生产能力近十亿元。

改革开放以来,集团公司以振兴民族医药为己任,积极推进企业改革,不断探索新的管理体制和运行机制,大力提高企业创新能力,促进了公司的全面发展,企业获得了比以往任何时候都好的社会效益和经济效益,创造了国有企业稳健经营的奇迹,综合实力跻身于全国企业500强和行业50强。近几年,集团大力实施科技兴业战略,确立了坚持以中药研发、生产和销售为主业,重点开发市场急需的小儿用药,老年用药和重大疑难病症用药,构建以中药现代化、产业化为基础,以高新技术药品为支撑的科技先导型医药集团。

目前,健民集团已成功地研制和开发出以龙牡壮骨颗粒、健民咽喉片、健脾生血颗粒、便通胶囊、慢肝宁胶囊为代表的系列产品,形成了集团蔚为壮观的"名牌林",产品行销全国,远销东南亚及欧美国家和地区。集团在近些年中相继荣获"全国质量效益型先进企业"、"全国中药行业优秀企业"、"全国五一劳动奖状"等称号,被誉为"搞好搞活国有企业的一面旗帜","健民"商标亦荣获"驰名保护"称号。一个以中药产业为基础,以高新科技为特征的健民集团必将在新的世纪里创更辉煌的业绩,谱写出振兴国药的优美乐章。

英文翻译:Longmu Zhuanggu Granule is a well-known brand under Wuhan Jianmin group, which has a glorious history of nearly 20 years and has created a long-lasting miracle in the field of Chinese medicine. It has nurtured the healthy growth of two generations of children in China. The main medicinal materials of Longmu Zhuanggu granules (such as Poria cocos, Ophiopogon japonicus, etc.) are directly selected from the gap medicinal materials planting base specially built by Wuhan Jianmin group, which are natural and authentic. There are strict quality control standards for each link and process in the production process, so that "unqualified raw materials are not allowed to enter the factory, unqualified semi-finished products are not transferred to the next process, and unqualified products are not allowed to leave the factory". The appearance and best-selling of "Longmu" has created amazing market performance and brand value, and also made Wuhan Jianmin, an enterprise with a long history but still young, full of vitality. Since then, it has been famous inside and outside the Great Wall, North and south of the river. "Longmu" once led the market of children's calcium supplement products. But now, it is faced with strong competition and challenge from other competitors, and the market share is constantly eroded and divided. He nurtured two generations of Chinese people. Born in Wuhan children's Hospital in 1985, it has filled in the blank of prevention and treatment of rickets in China with traditional Chinese medicine as the main body; in 1990, it was included in the drug standard of Hubei Province; in 1992, it was listed as the only one level of protection of traditional Chinese medicine for calcium supplement; in 1993, it was recommended as the best drug for children's calcium supplement and calcium absorption by China children's protection center; in 1994, it was recommended by the National Coordination Group for prevention and treatment of rickets It was listed as the first Chinese patent medicine; in 1995, it was listed in the drug standard of the Ministry of health; in 1999, it was listed as the national basic drug; in 2000, it was listed in the 2000 edition of the Chinese Pharmacopoeia; in 2002, it was listed as the national prescription medicine and over-the-counter medicine (OTC) double cross varieties; in the same year, it was listed in the pediatrics of traditional Chinese medicine (the textbook for the planning of the national higher education of traditional Chinese medicine in the new era). Wuhan Jianmin is one of the top 50 enterprises in China's pharmaceutical industry. The Group Co., Ltd. is a national key high-tech enterprise, a national production base of Chinese patent medicine for children and a national key Chinese medicine enterprise. The group's predecessor is Ye Kaitai drugstore, one of the four oldest famous traditional Chinese medicine stores in China. It has a history of nearly four centuries. Now it has more than ten subsidiaries, integrating production, scientific research and economic and trade, with an annual production capacity of nearly one billion yuan. Since the reform and opening up, the group company has taken the revitalization of national medicine as its own duty, actively promoted the enterprise reform, constantly explored new management system and operation mechanism, vigorously improved the innovation ability of the enterprise, promoted the overall development of the company, obtained better social and economic benefits than ever before, created a miracle of steady operation of state-owned enterprises, and its comprehensive strength ranks among Top 500 enterprises and top 50 industries in China. In recent years, the group has vigorously implemented the strategy of developing industry through science and technology, established a science and technology leading pharmaceutical group based on the modernization and industrialization of traditional Chinese medicine, supported by high-tech drugs, which adheres to the R & D, production and sales of traditional Chinese medicine as the main business, focuses on the development of children's drugs, elderly drugs and drugs for major and difficult diseases urgently needed in the market. At present, Jianmin group has successfully developed and developed a series of products represented by Longmu Zhuanggu granules, Jianmin Yanhou tablets, Jianpi Shengxue granules, Bentong capsules and manganning capsules, forming a spectacular "famous brand forest" of the group, which is sold all over the country and exported to Southeast Asia, European and American countries and regions. In recent years, the group has been awarded the titles of "national advanced quality and benefit enterprise", "national excellent enterprise in traditional Chinese medicine industry", "National May 1st Labor Award", etc., known as "a banner for invigorating state-owned enterprises", and the trademark of "invigorating the people" has also been awarded the title of "well-known protection". A Jianmin group based on traditional Chinese medicine industry and characterized by high and new technology is bound to make more brilliant achievements in the new century and compose a beautiful movement to revitalize traditional Chinese medicine.

本文链接: https://www.waitui.com/brand/ef134bbd9.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

中原证券:A股6月有望延续结构性行情 成长与价值继续轮动

中原证券表示,总体而言,6月A股在政策托底与盈利修复的共振下,有望延续结构性行情。一方面,5月公布的经济数据超预期,工业、消费、进出口均表现良好,为A股提供了基本面支撑。同时,9家股份制银行跟进下调存款利率,或将推动资金向权益市场迁移,为A股带来增量资金。另一方面,从政策层面来看,一揽子金融政策释放稳增长、降成本信号,如降准0.5个百分点、下调政策利率0.1个百分点、结构性货币政策工具和个人公积金贷款利率均下调0.25个百分点等,改善市场流动性环境,也有利于A股走势。配置方面,近期依旧是成长与价值的轮动格局,因此建议投资者关注两条主线:一是内需提振消费、产业需求的计算机、元器件、电子、通信板块;二是银行、煤炭、石油石化等低估值、高分红板块防御性板块。(财联社)

15分钟前

机构:6月核心城市房地产市场有望保持修复

中指研究院最新发布的《2025年1—5月中国房地产企业销售业绩排行榜》显示,5月单月,TOP100房企销售额同比下降17.3%,较4月单月降幅扩大0.5个百分点。中指研究院企业研究总监刘水表示,6月楼市政策环境预计将保持宽松基调,叠加年中销售节点来临,房企推盘节奏及促销力度或将加大,核心城市市场有望保持修复,但各城市之间、新老项目之间分化行情仍将延续。(e公司)

15分钟前

2025年端午节电影票房已超去年同期

猫眼专业版数据显示,截至5月31日18时13分,2025年端午节电影票房超1.17亿元,超越2024年端午节票房成绩,《碟中谍8:最终清算》暂列端午节首日票房冠军。(e公司)

16分钟前

重庆优化创业担保贷款政策

近期,重庆市人力社保局、市财政局、中国人民银行重庆市分行联合印发《关于调整优化我市创业担保贷款工作的通知》,个人创业担保贷款额度从30万元提升至50万元;小微企业贷款额度从400万元提升至600万元;合伙创业的个人贷款额度从33万元/人提升至55万元/人,贷款总额提升至600万元。对符合条件的创业担保贷款,财政部门给予最高0.5%/年的担保费补贴。以贷款50万元为例,每年可减少2500元担保费。同时规定,展期、逾期贷款原则上不享受补贴,既激励创业者诚信履约,又保障财政资金精准支持优质项目,实现政策效益最大化。(e公司)

16分钟前

江苏南通:多子女家庭购买新建商品住房的给予5万元一次性购房补贴

江苏省南通市住建局等八部门近日印发《关于促进全市房地产市场平稳健康发展若干措施的通知》。其中提及,给予多子女家庭购房补贴。对主城区(崇川区、南通经济技术开发区、苏锡通科技产业园区)范围内符合生育政策的多子女(二孩及以上)家庭购买新建商品住房的,给予5万元的一次性购房补贴。

16分钟前

本页详细列出关于龙牡的品牌信息,含品牌所属公司介绍,龙牡所处行业的品牌地位及优势。
咨询